Clinical trial

Safety Study of Subthalamic Nucleus Gene Therapy for Parkinson's Disease

NCT00195143

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-08-01

PhasePHASE1

Study timeline

Study start (unknown)2003-08-01Date precision: month

Registry last updated2008-03-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson's Diseaseunresolved

Interventions

Surgical infusion of AAV-GAD into the subthalamic nucleusGENETIC

Sponsors & collaborators

Neurologix, Inc.lead sponsor

Weill Medical College of Cornell Universitycollaborator

North Shore University Hospitalcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00195143 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.